PEPTONIC MEDICAL (F:28L) — Market Cap & Net Worth

$4.82 Million USD  · €4.12 Million EUR  · Rank #28443

Market Cap & Net Worth: PEPTONIC MEDICAL (28L)

PEPTONIC MEDICAL (F:28L) has a market capitalization of $4.82 Million (€4.12 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #28443 globally and #2474 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying PEPTONIC MEDICAL's stock price €0.00 by its total outstanding shares 20624009514 (20.62 Billion).

PEPTONIC MEDICAL Market Cap History: 2021 to 2026

PEPTONIC MEDICAL's market capitalization history from 2021 to 2026. Data shows change from $786.04 Million to $4.82 Million (-70.90% CAGR).

PEPTONIC MEDICAL Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how PEPTONIC MEDICAL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of 28L by Market Capitalization

Companies near PEPTONIC MEDICAL in the global market cap rankings as of May 5, 2026.

Key companies related to PEPTONIC MEDICAL by market ranking:

  • Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
  • Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
  • Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
  • GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#499 Takeda Pharmaceutical Co Ltd ADR NYSE:TAK $52.60 Billion $16.65
#525 Zoetis Inc NYSE:ZTS $50.31 Billion $114.16
#526 Jiangsu Hengrui Medicine Co Ltd SHG:600276 $50.29 Billion CN¥53.88
#572 GALDERMA GROUP AG NYSE:GALDY $45.88 Billion $42.15

PEPTONIC MEDICAL Historical Marketcap From 2021 to 2026

Between 2021 and today, PEPTONIC MEDICAL's market cap moved from $786.04 Million to $ 4.82 Million, with a yearly change of -70.90%.

Year Market Cap Change (%)
2026 €4.82 Million 0.00%
2025 €4.82 Million 0.00%
2024 €4.82 Million -95.24%
2023 €101.27 Million -39.13%
2022 €166.37 Million -78.83%
2021 €786.04 Million --

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of PEPTONIC MEDICAL was reported to be:

Source Market Cap
Yahoo Finance $4.82 Million USD
MoneyControl $4.82 Million USD
MarketWatch $4.82 Million USD
marketcap.company $4.82 Million USD
Reuters $4.82 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About PEPTONIC MEDICAL

F:28L Germany Drug Manufacturers - Specialty & Generic
Market Cap
$4.82 Million
€4.12 Million EUR
Market Cap Rank
#28443 Global
#2474 in Germany
Share Price
€0.00
Change (1 day)
+0.00%
52-Week Range
€0.00 - €0.00
All Time High
€0.12
About

PEPTONIC medical AB (publ), a medical technology company, develops and sells intimate self-care products for women. The company offers products under the VagiVital brand, including a moisturizing gel for atrophy; an intimate calming gel for rapid relief of itching and irritation; moisturizing lubricant; a pH-balancing intimate wash/conditioner; self-test kits for diagnosing pre-menopause, menopau… Read more